0001666071-21-000148.txt : 20210716
0001666071-21-000148.hdr.sgml : 20210716
20210716165047
ACCESSION NUMBER: 0001666071-21-000148
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210714
FILED AS OF DATE: 20210716
DATE AS OF CHANGE: 20210716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laube Lynne Marie
CENTRAL INDEX KEY: 0001730687
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 211095959
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_162646861487045.xml
FORM 4
X0306
4
2021-07-14
0
0001666071
Cardlytics, Inc.
CDLX
0001730687
Laube Lynne Marie
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
1
1
0
0
Chief Executive Officer
Common Stock
2021-07-14
4
M
0
3376
20
A
311708
D
Common Stock
2021-07-14
4
S
0
1976
123.77
D
309732
D
Common Stock
2021-07-14
4
S
0
1100
124.56
D
308632
D
Common Stock
2021-07-14
4
S
0
300
125.77
D
308332
D
Common Stock
2021-07-15
4
M
0
2138
20
A
310470
D
Common Stock
2021-07-15
4
S
0
300
120.42
D
310170
D
Common Stock
2021-07-15
4
S
0
400
122.29
D
309770
D
Common Stock
2021-07-15
4
S
0
638
123.03
D
309132
D
Common Stock
2021-07-15
4
S
0
700
124.95
D
308432
D
Common Stock
2021-07-15
4
S
0
100
125.56
D
308332
D
Common Stock
14565
I
See Footnote
Common Stock
14565
I
See Footnote
Employee Stock Option (Right to Buy)
20.0
2021-07-14
4
M
0
3376
0
D
2026-08-02
Common Stock
3376.0
44025
D
Employee Stock Option (Right to Buy)
20.0
2021-07-15
4
M
0
2138
0
D
2026-08-02
Common Stock
2138.0
41887
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $123.14 to $124.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.15 to $124.895, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.70 to $125.90, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $120.07 to $120.66, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.725 to $122.64, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $122.80 to $123.23, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.47 to $125.30, inclusive.
The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.
The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.
Fully vested.
/s/ Kirk Somers, Attorney-in-Fact
2021-07-16